Both in Biotechnology
Hemab Therapeutics Holdings vs Vir Biotechnology
Over the past year COAG returned +10.6% and VIR returned +6.3%; their daily moves had a correlation of 0.29.
COAG +10.6% VIR +6.3%Growth of $1, one year, split-adjusted
| Metric | COAG | VIR |
|---|---|---|
| Price | $43.56 | $11.29 |
| Market cap | $2.03B | $1.91B |
| Today | +5.78% | +2.64% |
| 1 month | +42.4% | −4.2% |
| 6 months | — | +12.8% |
| Year to date | — | +87.2% |
| 1 year | — | +89.4% |
| Revenue growth (YoY) | — | +19582.5% |
| Gross margin | — | 100.0% |
| Net margin | — | 33.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.3× |
| Net cash | $457.5M | $532.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 51.6% |
| Short % of float | 20.4% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).